NCT00581750View on ClinicalTrials.gov

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

CompletedOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Breast CancerLobular CarcinomaInvasive Breast Cancer
Interventions
OTHER

Tissue specimen

Human tissues taken after the clinically indicated removal of these tissues from patients as part of their routine care.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00581750 - Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ | Biotech Hunter | Biotech Hunter